Preliminary Observations of the Loke Microdialysis in an Experimental Pig Model: Are We Ready for Continuous Monitoring of Brain Energy Metabolism?
Brain injury
Energy metabolism
Loke
Microdialysis
Neurointensive care
Journal
Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086
Informations de publication
Date de publication:
31 Jul 2024
31 Jul 2024
Historique:
received:
18
04
2024
accepted:
10
07
2024
medline:
1
8
2024
pubmed:
1
8
2024
entrez:
31
7
2024
Statut:
aheadofprint
Résumé
Brain energy metabolism is often disturbed after acute brain injuries. Current neuromonitoring methods with cerebral microdialysis (CMD) are based on intermittent measurements (1-4 times/h), but such a low frequency could miss transient but important events. The solution may be the recently developed Loke microdialysis (MD), which provides high-frequency data of glucose and lactate. Before clinical implementation, the reliability and stability of Loke remain to be determined in vivo. The purpose of this study was to validate Loke MD in relation to the standard intermittent CMD method. Four pigs aged 2-3 months were included. They received two adjacent CMD catheters, one for standard intermittent assessments and one for continuous (Loke MD) assessments of glucose and lactate. The standard CMD was measured every 15 min. Continuous Loke MD was sampled every 2-3 s and was averaged over corresponding 15-min intervals for the statistical comparisons with standard CMD. Intravenous glucose injections and intracranial hypertension by inflation of an intracranial epidural balloon were performed to induce variations in intracranial pressure, cerebral perfusion pressure, and systemic and cerebral glucose and lactate levels. In a linear mixed-effect model of standard CMD glucose (mM), there was a fixed effect value (± standard error [SE]) at 0.94 ± 0.07 (p < 0.001) for Loke MD glucose (mM), with an intercept at - 0.19 ± 0.15 (p = 0.20). The model showed a conditional R The established standard CMD glucose thresholds may be used as for Loke MD with some caution, but this should be avoided for lactate.
Sections du résumé
BACKGROUND
BACKGROUND
Brain energy metabolism is often disturbed after acute brain injuries. Current neuromonitoring methods with cerebral microdialysis (CMD) are based on intermittent measurements (1-4 times/h), but such a low frequency could miss transient but important events. The solution may be the recently developed Loke microdialysis (MD), which provides high-frequency data of glucose and lactate. Before clinical implementation, the reliability and stability of Loke remain to be determined in vivo. The purpose of this study was to validate Loke MD in relation to the standard intermittent CMD method.
METHODS
METHODS
Four pigs aged 2-3 months were included. They received two adjacent CMD catheters, one for standard intermittent assessments and one for continuous (Loke MD) assessments of glucose and lactate. The standard CMD was measured every 15 min. Continuous Loke MD was sampled every 2-3 s and was averaged over corresponding 15-min intervals for the statistical comparisons with standard CMD. Intravenous glucose injections and intracranial hypertension by inflation of an intracranial epidural balloon were performed to induce variations in intracranial pressure, cerebral perfusion pressure, and systemic and cerebral glucose and lactate levels.
RESULTS
RESULTS
In a linear mixed-effect model of standard CMD glucose (mM), there was a fixed effect value (± standard error [SE]) at 0.94 ± 0.07 (p < 0.001) for Loke MD glucose (mM), with an intercept at - 0.19 ± 0.15 (p = 0.20). The model showed a conditional R
CONCLUSIONS
CONCLUSIONS
The established standard CMD glucose thresholds may be used as for Loke MD with some caution, but this should be avoided for lactate.
Identifiants
pubmed: 39085507
doi: 10.1007/s12028-024-02080-5
pii: 10.1007/s12028-024-02080-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Nordström CH. Cerebral energy metabolism and microdialysis in neurocritical care. Childs Nerv Syst. 2010;26(4):465–72.
doi: 10.1007/s00381-009-1035-z
pubmed: 19937248
Hillered L, Dahlin AP, Clausen F, Chu J, Bergquist J, Hjort K, et al. Cerebral microdialysis for protein biomarker monitoring in the neurointensive care setting - a technical approach. Front Neurol. 2014;5:245.
doi: 10.3389/fneur.2014.00245
pubmed: 25520696
pmcid: 4253950
Nordström CH, Koskinen LO, Olivecrona M. Aspects on the physiological and biochemical foundations of neurocritical care. Front Neurol. 2017;8:274.
doi: 10.3389/fneur.2017.00274
pubmed: 28674514
pmcid: 5474476
Svedung Wettervik T, Engquist H, Hånell A, Howells T, Rostami E, Ronne-Engström E, et al. Cerebral microdialysis monitoring of energy metabolism: relation to cerebral blood flow and oxygen delivery in aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2023;35(4):384–93.
doi: 10.1097/ANA.0000000000000854
pubmed: 35543615
Persson L, Hillered L. Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J Neurosurg. 1992;76(1):72–80.
doi: 10.3171/jns.1992.76.1.0072
pubmed: 1727172
Enblad P, Valtysson J, Andersson J, Lilja A, Valind S, Antoni G, et al. Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1996;16(4):637–44.
doi: 10.1097/00004647-199607000-00014
pubmed: 8964803
Ungerstedt U, Pycock C. Functional correlates of dopamine neurotransmission. Bull Schweiz Akad Med Wiss. 1974;30(1–3):44–55.
pubmed: 4371656
Hutchinson PJ, Jalloh I, Helmy A, Carpenter KL, Rostami E, Bellander BM, et al. Consensus statement from the 2014 international microdialysis forum. Intensive Care Med. 2015;41(9):1517–28.
doi: 10.1007/s00134-015-3930-y
pubmed: 26194024
pmcid: 4550654
Svedung Wettervik T, Howells T, Ronne-Engström E, Hillered L, Lewén A, Enblad P, et al. High arterial glucose is associated with poor pressure autoregulation, high cerebral lactate/pyruvate ratio and poor outcome following traumatic brain injury. Neurocrit Care. 2019;31(3):526–33.
doi: 10.1007/s12028-019-00743-2
pubmed: 31123993
pmcid: 6872512
Guilfoyle MR, Helmy A, Donnelly J, Stovell MG, Timofeev I, Pickard JD, et al. Characterising the dynamics of cerebral metabolic dysfunction following traumatic brain injury: a microdialysis study in 619 patients. PLoS ONE. 2021;16(12):e0260291.
doi: 10.1371/journal.pone.0260291
pubmed: 34914701
pmcid: 8675704
Vespa PM, McArthur D, O’Phelan K, Glenn T, Etchepare M, Kelly D, et al. Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab. 2003;23(7):865–77.
doi: 10.1097/01.WCB.0000076701.45782.EF
pubmed: 12843790
Timofeev I, Carpenter KL, Nortje J, Al-Rawi PG, O’Connell MT, Czosnyka M, et al. Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. Brain. 2011;134(Pt 2):484–94.
doi: 10.1093/brain/awq353
pubmed: 21247930
Svedung Wettervik T, Howells T, Hillered L, Rostami E, Lewén A, Enblad P. Autoregulatory or fixed cerebral perfusion pressure targets in traumatic brain injury: determining which is better in an energy metabolic perspective. J Neurotrauma. 2021;38(14):1969–78.
doi: 10.1089/neu.2020.7290
pubmed: 33504257
Svedung Wettervik T, Fahlström M, Enblad P, Lewén A. Cerebral pressure autoregulation in brain injury and disorders-a review on monitoring, management, and future directions. World Neurosurg. 2022;158:118–31.
doi: 10.1016/j.wneu.2021.11.027
pubmed: 34775084
Svedung Wettervik T, Lewén A, Enblad P. Fine tuning of neurointensive care in aneurysmal subarachnoid hemorrhage: from one-size-fits-all towards individualized care. World Neurosurg X. 2023;18:100160.
doi: 10.1016/j.wnsx.2023.100160
pubmed: 36818739
pmcid: 9932216
Svedung Wettervik TM, Lewén A, Enblad P. Fine tuning of traumatic brain injury management in neurointensive care-indicative observations and future perspectives. Front Neurol. 2021;12:638132.
doi: 10.3389/fneur.2021.638132
pubmed: 33716941
pmcid: 7943830
Lazaridis C. Brain shock-toward pathophysiologic phenotyping in traumatic brain injury. Crit Care Explor. 2022;4(7):e0724.
doi: 10.1097/CCE.0000000000000724
pubmed: 35815183
pmcid: 9257295
Gajavelli S, Sinha VK, Mazzeo AT, Spurlock MS, Lee SW, Ahmed AI, et al. Evidence to support mitochondrial neuroprotection, in severe traumatic brain injury. J Bioenerg Biomembr. 2015;47(1–2):133–48.
doi: 10.1007/s10863-014-9589-1
pubmed: 25358440
Marcoux J, McArthur DA, Miller C, Glenn TC, Villablanca P, Martin NA, et al. Persistent metabolic crisis as measured by elevated cerebral microdialysis lactate-pyruvate ratio predicts chronic frontal lobe brain atrophy after traumatic brain injury. Crit Care Med. 2008;36(10):2871–7.
doi: 10.1097/CCM.0b013e318186a4a0
pubmed: 18766106
Carney N, Totten AM, O’Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the management of severe traumatic brain injury. Neurosurgery. 2017;80(1):6–15.
doi: 10.1227/NEU.0000000000001432
pubmed: 27654000
Treggiari MM, Rabinstein AA, Busl KM, Caylor MM, Citerio G, Deem S, et al. Guidelines for the neurocritical care management of aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023;39(1):1–28.
doi: 10.1007/s12028-023-01713-5
pubmed: 37202712
Diaz-Parejo P, Ståhl N, Xu W, Reinstrup P, Ungerstedt U, Nordström CH. Cerebral energy metabolism during transient hyperglycemia in patients with severe brain trauma. Intensive Care Med. 2003;29(4):544–50.
doi: 10.1007/s00134-003-1669-3
pubmed: 12655390
Purins K, Enblad P, Wiklund L, Lewén A. Brain tissue oxygenation and cerebral perfusion pressure thresholds of ischemia in a standardized pig brain death model. Neurocrit Care. 2012;16(3):462–9.
doi: 10.1007/s12028-012-9675-3
pubmed: 22302179
R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2021.
Kramer DR, Fujii T, Ohiorhenuan I, Liu CY. Cortical spreading depolarization: pathophysiology, implications, and future directions. J Clin Neurosci. 2016;24:22–7.
doi: 10.1016/j.jocn.2015.08.004
pubmed: 26461911
Lee CY, Soliman H, Geraghty BJ, Chen AP, Connelly KA, Endre R, et al. Lactate topography of the human brain using hyperpolarized
doi: 10.1016/j.neuroimage.2019.116202
pubmed: 31557546
Dujmovic I, Deisenhammer F. Stability of cerebrospinal fluid/serum glucose ratio and cerebrospinal fluid lactate concentrations over 24 h: analysis of repeated measurements. Clin Chem Lab Med. 2010;48(2):209–12.
doi: 10.1515/CCLM.2010.040
pubmed: 19958211
Brook I. Stability of lactic acid in cerebrospinal fluid specimens. Am J Clin Pathol. 1982;77(2):213–6.
doi: 10.1093/ajcp/77.2.213
pubmed: 7064919
Hutchinson PJ, O’Connell MT, Al-Rawi PG, Maskell LB, Kett-White R, Gupta AK, et al. Clinical cerebral microdialysis: a methodological study. J Neurosurg. 2000;93(1):37–43.
doi: 10.3171/jns.2000.93.1.0037
pubmed: 10883903
Hutchinson PJ, O’Connell MT, Nortje J, Smith P, Al-Rawi PG, Gupta AK, et al. Cerebral microdialysis methodology—evaluation of 20 kDa and 100 kDa catheters. Physiol Meas. 2005;26(4):423–8.
doi: 10.1088/0967-3334/26/4/008
pubmed: 15886437